IRMCX
Price
$9.23
Change
+$0.07 (+0.76%)
Updated
Aug 13 closing price
Net Assets
807.95M
VIEIX
Price
$190.05
Change
+$0.37 (+0.20%)
Updated
Aug 14 closing price
Net Assets
93.63B
Interact to see
Advertisement

IRMCX vs VIEIX

IRMCX vs VIEIX Comparison Chart in %
View a ticker or compare two or three
VS
IRMCX vs. VIEIX commentary
Aug 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRMCX is a Buy and VIEIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIEIX has more cash in the bank: 93.6B vs. IRMCX (808M). VIEIX pays higher dividends than IRMCX: VIEIX (1.04) vs IRMCX (0.75). IRMCX was incepted earlier than VIEIX: IRMCX (18 years) vs VIEIX (29 years). IRMCX (0.84) is less costly to investors than VIEIX (0.04). IRMCX is a more actively managed with annual turnover of: 26.00 vs. VIEIX (12.00). IRMCX has a lower initial minimum investment than VIEIX: IRMCX (0) vs VIEIX (5000000). VIEIX annual gain was more profitable for investors over the last year : 25.08 vs. IRMCX (-11.16). VIEIX return over 5 years is better than : 35.77 vs. IRMCX (-29.55).
IRMCXVIEIXIRMCX / VIEIX
Total Expense Ratio0.650.041,625%
Annual Report Gross Expense Ratio0.840.042,100%
Fund Existence18 years29 years-
Gain YTD-13.31120.009-67%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets808M93.6B1%
Annual Yield % from dividends0.751.0472%
Returns for 1 year-11.1625.08-44%
Returns for 3 years-6.0269.85-9%
Returns for 5 years-29.5535.77-83%
Returns for 10 years-28.54187.62-15%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NRGSX63.080.17
+0.27%
Neuberger Genesis R6
GCVAX29.84N/A
N/A
Goldman Sachs Large Cp Val Insghts A
QOPYX25.77N/A
N/A
Invesco Multi-Strategy Fund Y
TRPBX27.30N/A
N/A
T. Rowe Price Spectrum Moderate Allc Inv
MPEMX11.15N/A
N/A
Mondrian Emerging Markets Value Equity